Corrado Advisors, LLC Catalyst Pharmaceuticals, Inc. Transaction History

Corrado Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 09, 2018	SELL	$2.26 - $3.84 $113,225 - $192,384	-50,100 Closed	0 $0
Q1 2018 Apr 06, 2018	SELL	$2.39 - $4.01 $27,485 - $46,115	-11,500 Reduced 18.67%	50,100 $120,000
Q4 2017 Jan 10, 2018	SELL	$2.51 - $4.4 $84,085 - $147,400	-33,500 Reduced 35.23%	61,600 $241,000
Q3 2017 Oct 06, 2017	BUY	$2.4 - $2.94 $228,240 - $279,594	95,100	95,100 $240,000

348

98.4M

13.4K

11.7K

Ticker CPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 102,820,000
Market Cap $2.54B
Description
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...

Get notified when there are updates to the investment portfolio of Corrado Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Corrado Advisors, LLC with notifications on news.